Wolverine Asset Management’s Reviva Pharmaceuticals RVPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $168 | Buy |
+442
| New | +$168 | ﹤0.01% | 1097 |
|
|
2025
Q1 | – | Sell |
-122
| Closed | -$220 | – | 1373 |
|
|
2024
Q4 | $220 | Sell |
122
-3,433
| -97% | -$6.19K | ﹤0.01% | 1134 |
|
|
2024
Q3 | $5.12K | Sell |
3,555
-975
| -22% | -$1.4K | ﹤0.01% | 957 |
|
|
2024
Q2 | $5.8K | Buy |
4,530
+1,155
| +34% | +$1.48K | ﹤0.01% | 970 |
|
|
2024
Q1 | $12.8K | Sell |
3,375
-1,274
| -27% | -$4.82K | ﹤0.01% | 879 |
|
|
2023
Q4 | $23.9K | Sell |
4,649
-9,351
| -67% | -$48.2K | ﹤0.01% | 890 |
|
|
2023
Q3 | $68.3K | Sell |
14,000
-501
| -3% | -$2.45K | ﹤0.01% | 831 |
|
|
2023
Q2 | $85K | Buy |
14,501
+8,397
| +138% | +$49.2K | ﹤0.01% | 771 |
|
|
2023
Q1 | $25.6K | Sell |
6,104
-710
| -10% | -$2.98K | ﹤0.01% | 977 |
|
|
2022
Q4 | $29K | Buy |
6,814
+6,155
| +934% | +$26.2K | ﹤0.01% | 1101 |
|
|
2022
Q3 | $1K | Hold |
659
| – | – | ﹤0.01% | 1944 |
|
|
2022
Q2 | $0 | Hold |
659
| – | – | ﹤0.01% | 2196 |
|
|
2022
Q1 | $1K | Buy |
659
+482
| +272% | +$731 | ﹤0.01% | 1852 |
|
|
2021
Q4 | $0 | Buy |
+177
| New | – | ﹤0.01% | 1919 |
|
|
2021
Q2 | – | Sell |
-3,078
| Closed | -$17K | – | 2162 |
|
|
2021
Q1 | $17K | Buy |
+3,078
| New | +$17K | ﹤0.01% | 1530 |
|
|
2020
Q2 | – | Sell |
-75,000
| Closed | -$789K | – | 1484 |
|
|
2020
Q1 | $789K | Buy |
+75,000
| New | +$789K | 0.01% | 443 |
|